We probably shouldn't gloss over the fact that this is their largest quarterly customer receipts...by a long way (at least based on the last two years):
The table above has some fairly simplistic assumptions. I've excluded all rebates and incentives from the CFO (Cash Flow from Operations) to get a more accurate view on PIQ's ability to generate cash. Adding back the R&D spend should hopefully get a view of the analytical business unit + any PromarkerD revenue. This is not perfect because it's reliant on cost allocation. However, it tells an important story about how significant this quarter just gone was...but to your point@Eqz, it would be great to know what the revenue split was...
- Forums
- ASX - By Stock
- PIQ
- Ann: Appendix 4C and Quarterly Report - March 2020
PIQ
proteomics international laboratories ltd
Add to My Watchlist
1.54%
!
32.0¢

Ann: Appendix 4C and Quarterly Report - March 2020, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $52.32M |
Open | High | Low | Value | Volume |
33.5¢ | 34.5¢ | 28.5¢ | $153.4K | 483.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 7853 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 17018 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7853 | 0.310 |
2 | 1614 | 0.305 |
4 | 75000 | 0.300 |
1 | 10172 | 0.295 |
1 | 150000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 17018 | 1 |
0.325 | 45249 | 1 |
0.330 | 58025 | 3 |
0.335 | 614 | 1 |
0.350 | 20625 | 2 |
Last trade - 14.06pm 25/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |